FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2783996679> ?p ?o ?g. }

• W2783996679 endingPage "1127" @default.
• W2783996679 startingPage "1108" @default.
• W2783996679 abstract "Adiponectin exerts renoprotective effects against diabetic nephropathy (DN) by activating the AMP-activated protein kinase (AMPK)/peroxisome proliferative-activated receptor– α (PPAR α ) pathway through adiponectin receptors (AdipoRs). AdipoRon is an orally active synthetic adiponectin receptor agonist. We investigated the expression of AdipoRs and the associated intracellular pathways in 27 patients with type 2 diabetes and examined the effects of AdipoRon on DN development in male C57BLKS/J db/db mice, glomerular endothelial cells (GECs), and podocytes. The extent of glomerulosclerosis and tubulointerstitial fibrosis correlated with renal function deterioration in human kidneys. Expression of AdipoR1, AdipoR2, and Ca 2+ /calmodulin-dependent protein kinase kinase– β (CaMKK β ) and numbers of phosphorylated liver kinase B1 (LKB1)– and AMPK-positive cells significantly decreased in the glomeruli of early stage human DN. AdipoRon treatment restored diabetes-induced renal alterations in db/db mice. AdipoRon exerted renoprotective effects by directly activating intrarenal AdipoR1 and AdipoR2, which increased CaMKK β , phosphorylated Ser 431 LKB1, phosphorylated Thr 172 AMPK, and PPAR α expression independently of the systemic effects of adiponectin. AdipoRon-induced improvement in diabetes-induced oxidative stress and inhibition of apoptosis in the kidneys ameliorated relevant intracellular pathways associated with lipid accumulation and endothelial dysfunction. In high-glucose–treated human GECs and murine podocytes, AdipoRon increased intracellular Ca 2+ levels that activated a CaMKK β /phosphorylated Ser 431 LKB1/phosphorylated Thr 172 AMPK/PPAR α pathway and downstream signaling, thus decreasing high-glucose–induced oxidative stress and apoptosis and improving endothelial dysfunction. AdipoRon further produced cardioprotective effects through the same pathway demonstrated in the kidney. Our results show that AdipoRon ameliorates GEC and podocyte injury by activating the intracellular Ca 2+ /LKB1-AMPK/PPAR α pathway, suggesting its efficacy for treating type 2 diabetes–associated DN." @default.
• W2783996679 created "2018-01-26" @default.
• W2783996679 creator A5004884422 @default.
• W2783996679 creator A5005288913 @default.
• W2783996679 creator A5011073372 @default.
• W2783996679 creator A5017354929 @default.
• W2783996679 creator A5028514834 @default.
• W2783996679 creator A5052148824 @default.
• W2783996679 creator A5052328556 @default.
• W2783996679 creator A5065254353 @default.
• W2783996679 creator A5077183139 @default.
• W2783996679 creator A5081345276 @default.
• W2783996679 date "2018-01-12" @default.
• W2783996679 modified "2023-10-11" @default.
• W2783996679 title "The Adiponectin Receptor Agonist AdipoRon Ameliorates Diabetic Nephropathy in a Model of Type 2 Diabetes" @default.
• W2783996679 cites W1587875569 @default.
• W2783996679 cites W1933040215 @default.
• W2783996679 cites W1966775855 @default.
• W2783996679 cites W1967568586 @default.
• W2783996679 cites W1969703390 @default.
• W2783996679 cites W1970205234 @default.
• W2783996679 cites W1973591364 @default.
• W2783996679 cites W1974203836 @default.
• W2783996679 cites W1985113583 @default.
• W2783996679 cites W1990886132 @default.
• W2783996679 cites W1993132387 @default.
• W2783996679 cites W1994041994 @default.
• W2783996679 cites W1999055087 @default.
• W2783996679 cites W2004744807 @default.
• W2783996679 cites W2009190806 @default.
• W2783996679 cites W2017073557 @default.
• W2783996679 cites W2031800834 @default.
• W2783996679 cites W2041446873 @default.
• W2783996679 cites W2042706232 @default.
• W2783996679 cites W2044386584 @default.
• W2783996679 cites W2054868264 @default.
• W2783996679 cites W2055726721 @default.
• W2783996679 cites W2074894911 @default.
• W2783996679 cites W2079140301 @default.
• W2783996679 cites W2095454212 @default.
• W2783996679 cites W2096530603 @default.
• W2783996679 cites W2100580464 @default.
• W2783996679 cites W2102677290 @default.
• W2783996679 cites W2108931588 @default.
• W2783996679 cites W2110304266 @default.
• W2783996679 cites W2120001839 @default.
• W2783996679 cites W2121120164 @default.
• W2783996679 cites W2124349057 @default.
• W2783996679 cites W2132124003 @default.
• W2783996679 cites W2134100055 @default.
• W2783996679 cites W2136249944 @default.
• W2783996679 cites W2138367727 @default.
• W2783996679 cites W2184009762 @default.
• W2783996679 cites W2610348712 @default.
• W2783996679 cites W330496103 @default.
• W2783996679 doi "https://doi.org/10.1681/asn.2017060627" @default.
• W2783996679 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5875945" @default.
• W2783996679 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29330340" @default.
• W2783996679 hasPublicationYear "2018" @default.
• W2783996679 type Work @default.
• W2783996679 sameAs 2783996679 @default.
• W2783996679 citedByCount "116" @default.
• W2783996679 countsByYear W27839966792018 @default.
• W2783996679 countsByYear W27839966792019 @default.
• W2783996679 countsByYear W27839966792020 @default.
• W2783996679 countsByYear W27839966792021 @default.
• W2783996679 countsByYear W27839966792022 @default.
• W2783996679 countsByYear W27839966792023 @default.
• W2783996679 crossrefType "journal-article" @default.
• W2783996679 hasAuthorship W2783996679A5004884422 @default.
• W2783996679 hasAuthorship W2783996679A5005288913 @default.
• W2783996679 hasAuthorship W2783996679A5011073372 @default.
• W2783996679 hasAuthorship W2783996679A5017354929 @default.
• W2783996679 hasAuthorship W2783996679A5028514834 @default.
• W2783996679 hasAuthorship W2783996679A5052148824 @default.
• W2783996679 hasAuthorship W2783996679A5052328556 @default.
• W2783996679 hasAuthorship W2783996679A5065254353 @default.
• W2783996679 hasAuthorship W2783996679A5077183139 @default.
• W2783996679 hasAuthorship W2783996679A5081345276 @default.
• W2783996679 hasBestOaLocation W27839966791 @default.
• W2783996679 hasConcept C126322002 @default.
• W2783996679 hasConcept C134018914 @default.
• W2783996679 hasConcept C184235292 @default.
• W2783996679 hasConcept C185592680 @default.
• W2783996679 hasConcept C2776780712 @default.
• W2783996679 hasConcept C2776782570 @default.
• W2783996679 hasConcept C2777391703 @default.
• W2783996679 hasConcept C2779183219 @default.
• W2783996679 hasConcept C2779922275 @default.
• W2783996679 hasConcept C2780091579 @default.
• W2783996679 hasConcept C2780124434 @default.
• W2783996679 hasConcept C55493867 @default.
• W2783996679 hasConcept C555293320 @default.
• W2783996679 hasConcept C71924100 @default.
• W2783996679 hasConcept C86803240 @default.
• W2783996679 hasConcept C97029542 @default.
• W2783996679 hasConceptScore W2783996679C126322002 @default.
• W2783996679 hasConceptScore W2783996679C134018914 @default.

• next